RADMILA MALLAH: Open Payments
NPI 1245558832 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,111 in 39 payments from 18 companies in 2025. Trend: 2023 $246 · 2024 $341 · 2025 $1,111
Food & beverage: $1,111
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $292 |
| Phathom Pharmaceuticals, Inc. | 2 | $144 |
| Otsuka America Pharmaceutical, Inc. | 4 | $102 |
| Janssen Pharmaceuticals, Inc | 2 | $79 |
| PFIZER INC. | 3 | $68 |
| Amgen Inc. | 3 | $53 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| Lilly USA, LLC | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| Exact Sciences Corporation | 1 | $35 |
Products named: AIRSUPRA, VOQUEZNA, REXULTI, SPRAVATO, SHINGRIX, NURTEC ODT, MOUNJARO, FARXIGA.
Industry payments across PA — which companies pay providers there.
